title: Hypertension and progressive supranuclear palsy: is everything so clear?
authors.forename: Igor
authors.initials: I
authors.lastname: Sibon
authors.forename: Frédéric
authors.initials: F
authors.lastname: Macia
authors.forename: Anne
authors.initials: A
authors.lastname: Vital
authors.forename: André
authors.initials: A
authors.lastname: Delacourte
authors.forename: François
authors.initials: F
authors.lastname: Tison
mesh_terms: D000368:Aged; D000906:Antibodies / Q000276:immunology; D001921:Brain / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008279:Magnetic Resonance Imaging; D008297:Male; D009419:Nerve Tissue Proteins / Q000276:immunology / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D013494:Supranuclear Palsy, Progressive / Q000150:complications* / Q000378:metabolism / Q000473:pathology*; D016875:tau Proteins
chemical_list: D000906:Antibodies; C054369:MAPT protein, human; D009419:Nerve Tissue Proteins; D016875:tau Proteins